Pierfrancesco Tassone

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Venues

Journal of translational medicine

Cancers

International journal of molecular sciences

Biomedicines

This page only lists publications with an associated author ORCID identifier.

Publications

Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, Pierosandro Tagliaferri, Vito Barbieri
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC). Cancers 16 (10) (2024)
Katia Grillone, Giulio Caridà, Francesco Luciano, Alessia Cordua, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. Journal of translational medicine 22 (1) (2024)
Katia Grillone, Giulio Caridà, Francesco Luciano, Alessia Cordua, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. Journal of translational medicine 22 (1) (2024)
Lydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, Francesca Scionti, Domenico Ciliberto, Nicoletta Staropoli, Giuseppe Agapito, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri, Aurelio Seidita, Maria Giovanna Minissale, Marco Affronti, Gaetano Bertino, Maurizio Russello, Rosaria Ciriminna, Claudia Lino, Francesca Spinnato, Francesco Verderame, Giuseppa Augello, Mariamena Arbitrio
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma. International journal of molecular sciences 25 (4) (2024)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, Pierosandro Tagliaferri, Vito Barbieri
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC). Cancers 16 (10) (2024)
Lydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, Francesca Scionti, Domenico Ciliberto, Nicoletta Staropoli, Giuseppe Agapito, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri, Aurelio Seidita, Maria Giovanna Minissale, Marco Affronti, Gaetano Bertino, Maurizio Russello, Rosaria Ciriminna, Claudia Lino, Francesca Spinnato, Francesco Verderame, Giuseppa Augello, Mariamena Arbitrio
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma. International journal of molecular sciences 25 (4) (2024)
Lydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, Francesca Scionti, Domenico Ciliberto, Nicoletta Staropoli, Giuseppe Agapito, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri, Aurelio Seidita, Maria Giovanna Minissale, Marco Affronti, Gaetano Bertino, Maurizio Russello, Rosaria Ciriminna, Claudia Lino, Francesca Spinnato, Francesco Verderame, Giuseppa Augello, Mariamena Arbitrio
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma. International journal of molecular sciences 25 (4) (2024)
Katia Grillone, Giulio Caridà, Francesco Luciano, Alessia Cordua, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. Journal of translational medicine 22 (1) (2024)
Daniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, Francesco Conforti, Stefania Signorelli, Alessandro Gulino, Nicoletta Staropoli, Franca Maria Tuccillo, Patrizia Bonelli, Giada Juli, Katia Grillone, Serena Ascrizzi, Maria Cirillo, Leonardo Migale, Andrea Ballerini, Cristina Pelizon, Maria Teresa Di Martino, Pierosandro Tagliaferri, Caterina Riillo, Pierfrancesco Tassone
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma. British journal of haematology (2023)
Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of translational medicine 21 (1) (2023)
Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of translational medicine 21 (1) (2023)
Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of translational medicine 21 (1) (2023)
Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of translational medicine 21 (1) (2023)
Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer. Journal of translational medicine 21 (1) (2023)
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticò, Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco Tassone
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. Cancers 15 (6) (2023)
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticò, Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco Tassone
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. Cancers 15 (6) (2023)
Serena Ascrizzi, Grazia Maria Arillotta, Katia Grillone, Giulio Caridà, Stefania Signorelli, Asad Ali, Caterina Romeo, Pierfrancesco Tassone, Pierosandro Tagliaferri
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice. Cancers 15 (15) (2023)
Katia Grillone, Caterina Riillo, Roberta Rocca, Serena Ascrizzi, Virginia Spanò, Francesca Scionti, Nicoletta Polerà, Annalisa Maruca, Marilia Barreca, Giada Juli, Mariamena Arbitrio, Maria Teresa Di Martino, Daniele Caracciolo, Pierosandro Tagliaferri, Stefano Alcaro, Alessandra Montalbano, Paola Barraja, Pierfrancesco Tassone
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma. International journal of molecular sciences 23 (18) (2022)
Daniele Caracciolo, Giada Juli, Caterina Riillo, Adriana Coricello, Francesca Vasile, Sara Pollastri, Roberta Rocca, Francesca Scionti, Nicoletta Polerà, Katia Grillone, Mariamena Arbitrio, Nicoletta Staropoli, Basilio Caparello, Domenico Britti, Giovanni Loprete, Giosuè Costa, Maria Teresa Di Martino, Stefano Alcaro, Pierosandro Tagliaferri, Pierfrancesco Tassone
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin. Journal of translational medicine 20 (1) (2022)
Roberta Rocca, Francesca Scionti, Matteo Nadai, Federica Moraca, Annalisa Maruca, Giosuè Costa, Raffaella Catalano, Giada Juli, Maria Teresa Di Martino, Francesco Ortuso, Stefano Alcaro, Pierosandro Tagliaferri, Pierfrancesco Tassone, Sara N Richter, Anna Artese
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Caterina Riillo, Daniele Caracciolo, Katia Grillone, Nicoletta Polerà, Franca Maria Tuccillo, Patrizia Bonelli, Giada Juli, Serena Ascrizzi, Francesca Scionti, Mariamena Arbitrio, Mariangela Lopreiato, Maria Anna Siciliano, Simona Sestito, Gabriella Talarico, Eulalia Galea, Maria Concetta Galati, Licia Pensabene, Giovanni Loprete, Marco Rossi, Andrea Ballerini, Massimo Gentile, Domenico Britti, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells. Cancers 14 (12) (2022)
Francesca Scionti, Giuseppe Agapito, Daniele Caracciolo, Caterina Riillo, Katia Grillone, Mario Cannataro, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone, Mariamena Arbitrio
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes. Cells 11 (2) (2022)
Nicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, Francesca Scionti, Domenico Ciliberto, Rossana Ingargiola, Caterina Labanca, Giuseppe Agapito, Eleonora Iuliano, Vito Barbieri, Maria Cucè, Valeria Zuccalà, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics. Biomedicines 10 (5) (2022)
Raffaella Catalano, Annalisa Maruca, Roberta Rocca, Pierfrancesco Tassone, Giulia Panzarella, Giosuè Costa, Francesco Ortuso, Stefano Alcaro
Identification of SET/EED dual binders as innovative PRC2 inhibitors. Future medicinal chemistry 14 (9) (2022)
Valerio Nardone, Rocco Giannicola, Diana Giannarelli, Rita Emilena Saladino, Domenico Azzarello, Caterina Romeo, Giovanna Bianco, Maria Rosaria Rizzo, Irene Di Meo, Antonio Nesci, Pierpaolo Pastina, Antonia Consuelo Falzea, Daniele Caracciolo, Alfonso Reginelli, Michele Caraglia, Amalia Luce, Luciano Mutti, Antonio Giordano, Salvatore Cappabianca, Luigi Pirtoli, Vito Barbieri, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pierpaolo Correale
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis. Life (Basel, Switzerland) 11 (11) (2021)
Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino, Daniele Caracciolo, Licia Pensabene, Pierfrancesco Tassone, Pierosandro Tagliaferri
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice. Clinical and translational science 14 (1) (2020)

Pierfrancesco Tassone.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierfrancesco Tassone